In humans, it has been suggested an increased MS susceptibility based on IL4 gene polymorphism [194] and elevated serum level of IL-4 in neuromyelitis optica and MS, but without any significant difference between them [195]. This evidence concerns the gene IL4 and myeloid sarcoma.